“As the market gets weighed down by a flood of new tariff announcements, Dow slipping 279 points, S&P declining 0.33%, Nasdaq dipping 0.22%, we have to remember that stocks ...
Keep Reading →
July 15 - Hedge Funds, News
Abbott Laboratories (NYSE:ABT) is one of the top 10 defensive stocks to consider in a volatile market.
Keep Reading →
July 9 - News
Investor positioning in defensive stock is at its lowest level it has ever been since 2000.
Keep Reading →
July 9 - Hedge Funds, News
Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc.
Keep Reading →
July 4 - News
On June 24, Chris Hyzy, Merrill and BofA Private Bank CIO, joined 'Closing Bell' on CNBC to discuss his bullish outlook on the stock market.
Keep Reading →
July 2 - Hedge Funds, News
[caption id="attachment_1196376" align="aligncenter" width="1456"] An operating room with a doctor monitoring a patient's vital signs during surgery with a medical device.[/caption...
Keep Reading →
June 28 - News
After underperforming the market in seven of the past eight years, the Morningstar Dividend Leaders Index has made a strong comeback in 2025.
Keep Reading →
June 26 - Dividend Stocks, Hedge Funds, News
Abbott Laboratories (NYSE:ABT) ranks among the top stocks for an early retirement portfolio.
Keep Reading →
June 25 - News
This week, Federal Reserve officials have the opportunity to discuss their views on interest rate trends, the effects of tariffs, and the economic effects of the Middle East crisis...
Keep Reading →
June 24 - Hedge Funds, News, Retirement
The company is a Dividend King with 53 consecutive years of dividend growth. Its five-year average annual dividend growth rate sits at nearly 11%.
Keep Reading →
June 18 - News
Abbott Laboratories (NYSE:ABT) is one of the best stocks to buy for beginners now. On June 10, Tandem Diabetes Care Inc.
Keep Reading →
June 17 - News
On June 12, Dan Niles, Niles Investment Management founder and portfolio manager, joined CNBC's 'Squawk Box' to discuss the state of the economy and how he expects the market ...
Keep Reading →
June 16 - Hedge Funds, News
Abbott Laboratories (NYSE:ABT) is one of the 17 stocks that Jim Cramer commented on.
Keep Reading →
June 15 - Hedge Funds, News
On Friday, Mad Money host Jim Cramer shared his evolving view of Elon Musk’s company as he provided both praise and caution in light of recent developments involving Musk and...
Keep Reading →
June 11 - Hedge Funds, News
Abbott Laboratories (NYSE:ABT) has received FDA approval today for its Tendyne™ transcatheter mitral valve replacement (TMVR) system, the first device of its kind approved in...
Keep Reading →
May 27 - News
Polen Capital, an investment management company, released its “Polen Global Growth Strategy” first-quarter 2025 investor letter.
Keep Reading →
May 23 - Hedge Fund Investor Letters, News
We recently published a list of Jim Cramer Nailed These 11 Stock Predictions.
Keep Reading →
May 23 - News
“Stories like the US debt downgrade story from Friday, they are classic… Stories that scare people out of very fine stocks that could otherwise make them rich.
Keep Reading →
May 22 - Hedge Funds, News
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Growth & Income Fund” first quarter 2025 investor letter.
Keep Reading →
May 20 - Hedge Fund Investor Letters, News
Dividend-paying stocks are drawing increased attention from investors amid this year’s market volatility.
Keep Reading →
May 18 - Dividend Stocks, Hedge Funds, News
Abbott Laboratories (NYSE:ABT) recently shared findings from its REFLECT real-world studies, revealing that the use of its FreeStyle Libre® continuous glucose monitoring (CGM...
Keep Reading →
May 18 - News
Diamond Hill Capital, an investment management company, released its “Large Cap Fund” first-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
May 12 - Hedge Fund Investor Letters, News
On April 16, CNBC reported that Trump's tariffs are building a divide in the medical community.
Keep Reading →
May 7 - Hedge Funds, Industries, News
Mairs & Power, an investment advisor, released the “Mairs & Power Balanced Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
May 7 - Hedge Fund Investor Letters, News
On Monday, Jim Cramer, host of Mad Money, shared valuable insights from his years of experience as an investor.
Keep Reading →
May 6 - Hedge Funds, News
During the most recent episode of Mad Money, Jim Cramer revisited the recent turbulence in artificial intelligence stocks, three months after the emergence of DeepSeek, a Chinese...
Keep Reading →
April 30 - Hedge Funds, News
As per BlackRock, 2025 started with a bumpy ride for the US stocks.
Keep Reading →
April 27 - Hedge Funds, News
In his latest appearance on CNBC’s Squawk on the Street, Jim Cramer highlighted the often-overlooked role of currency fluctuations and explained why a weaker U.S.
Keep Reading →
April 18 - Hedge Funds, News
Operator: Good morning, and thank you for standing by. Welcome to Abbott Laboratories' First Quarter 2025 Earnings Conference Call.
Keep Reading →
April 18 - News, Transcripts
In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S.
Keep Reading →
April 16 - Hedge Funds, News
Dividend-focused investors are generally well-acquainted with terms like Dividend Aristocrats and Dividend Kings, but many may not be aware of a lesser-known group called Dividend...
Keep Reading →
April 15 - Dividend Stocks, Hedge Funds, News
He noted the chaotic nature of the current environment and remarked that "this tape has it all," and emphasized how unpredictable developments from the White House have added ...
Keep Reading →
April 14 - Hedge Funds, News
When it comes to profits, dividend investing is the first thing that springs to mind.
Keep Reading →
April 7 - Dividend Stocks, Hedge Funds, News
The importance of dividend stocks cannot be denied, even in today’s market environment, which is dominated by AI stocks.
Keep Reading →
April 5 - Dividend Stocks, Hedge Funds, News
Dividend stocks have been attracting increasing interest lately, particularly following the tech sector’s sharp decline in March.
Keep Reading →
March 26 - Dividend Stocks, Hedge Funds, News
Heather Brilliant, CFA, serves as CEO for Diamond Hill Capital and joined the firm in 2019, bringing over 20 years of domestic and international investment industry experience...
Keep Reading →
March 24 - Hedge Funds, News
The broader market has posted consecutive annual gains of 25%, largely fueled by growth stocks and companies capitalizing on the rising demand for artificial intelligence.
Keep Reading →
March 24 - Dividend Stocks, Hedge Funds, News
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer reiterated that the Trump administration has to clarify its narrative about tariffs to convince the average American...
Keep Reading →
March 19 - News
The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income countries.
Keep Reading →
March 14 - Hedge Funds, News
In the US, healthcare expenditures and costs have been increasing.
Keep Reading →
March 12 - Hedge Funds, News
Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for medicines in China.
Keep Reading →
February 16 - Hedge Funds, Industries, News
Jim Cramer, host of Mad Money, recently offered some important advice on how young people should approach investing and managing their money.
Keep Reading →
February 13 - Hedge Funds, News
According to a report by Mordor Intelligence, the medical devices market has a size of $681.57 billion as of 2025.
Keep Reading →
February 10 - Hedge Funds, Industries, News
In this article, we will take a look at 12 stocks that Jim Cramer discussed 6 months ago during his show on July 29, 2024, and examine whether he was right or wrong about those...
Keep Reading →
February 7 - Hedge Funds, News
Jim Cramer, the host of Mad Money, took a moment on Wednesday to reflect on the latest market developments as earnings season progresses, sharing his thoughts on how investors...
Keep Reading →
February 6 - Hedge Funds, News
Cancer is the second leading cause of death across the globe, second to cardiovascular disease.
Keep Reading →
February 2 - Hedge Funds, News
On the day that Wall Street's favorite AI GPU stock bled 17% in the wake of investors panicking about Chinese AI startup DeepSeek's low development costs for AI, Jim Cramer had...
Keep Reading →
January 29 - News
In his recent appearance on CNBC's Squawk on the Street, Jim Cramer started the morning by commenting on the S&P's best eight-session rally since August.
Keep Reading →
January 29 - News
Jim Cramer in a latest program on CNBC discussed the reasons behind the recent market declines after the ISM Services Index data.
Keep Reading →
January 25 - Hedge Funds, News
Abbott Laboratories (NYSE:ABT) Q4 2024 Earnings Call Transcript January 22, 2025Abbott Laboratories reports earnings inline with expectations.
Keep Reading →
January 23 - News, Transcripts